Guardant Health Inc annual operating income for fiscal TTM was -$470 million, a decrease of 7.8% from -$436 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($470M) | ($436M) | ($444M) | ($565M) | ($544M) | ($411M) | ($255M) | ($82M) | ($93M) | ($77M) | ($44M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($129M) | ($121M) | ($121M) | ($99M) | ($106M) | ($111M) | ($126M) | ($117M) | ($101M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources · Privacy · Terms